Baxter International Inc.

Baxter International Inc., founded in 1931 and headquartered in Deerfield, Illinois, United States, is a global healthcare company focused on innovative medical devices, pharmaceuticals, and biotechnology products. It is best known for its advanced renal care systems, infusion pumps, and sterile solutions, which drive recurring revenue across hospitals and home care segments. Under the leadership of CEO José E. Almeida since 2016, Baxter maintains a top-five global ranking in its core markets. The company is actively investing in next-generation therapies and digital health initiatives while expanding its footprint in emerging markets.

Baxter has a Board-authorized share repurchase program (originally authorized July 2012 and increased several times) with approximately $1.30 billion remaining available; the company did not repurchase any shares under this authority in 2025, 2024, or the first quarter of 2026.